Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 7, 2015; 21(5): 1404-1413
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1404
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1404
Table 1 Current suggested pharmacological therapy for the management of pruritis associated with jaundice[101]
| Treatment | Agent | Dosage |
| Initial | UDCA | 10-15 mg/kg.d (PO) |
| First line | Cholestyramine | 4-16 g/d (PO) |
| Second line | Rifampicin | 300-600 mg/d (PO) |
| Third line | Naltrexone | 50 mg/d (PO) |
| Fourth line | Sertraline | 100 mg/d (PO) |
- Citation: Bassari R, Koea JB. Jaundice associated pruritis: A review of pathophysiology and treatment. World J Gastroenterol 2015; 21(5): 1404-1413
- URL: https://www.wjgnet.com/1007-9327/full/v21/i5/1404.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i5.1404